ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $675K of Zentalis Pharmaceuticals, Inc.
Sold$675,229
$67.52Price
10,000Shares
−2%Stake
What ZNTL did after the filing
- The stock from Thu, Sep 2 close, $66.92
- +11.9%
- S&P 500, same days
- −1.3%
Measured over 30 trading days, to the Oct 15 close.
Traded Wed, Sep 1. Filed Thu, Sep 2, 3:32 PM ET, during the session. Returns use the Sep 2 close and the Oct 15 close. Not investment advice.